⌘K

16:15:44·808d

13D/GFilingvia Quantisnow

SEC Form SC 13G/A filed by Pacific Biosciences of California Inc. (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

PACB· Pacific Biosciences of California Inc.

Industrials

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

PACB
Pacific Biosciences of California Inc.
Industrials

Recent analyst ratings

Mar 6UpdateBarclays$1.50
Nov 11UpdateUBS-
Jun 3UpdateJefferies$4.00
Apr 22UpdateJP Morgan-
Apr 18UpdateGoldman$2.50
Dec 14UpdateStephens$11.00

Related

SEC8d
SEC Form DEFA14A filed by Pacific Biosciences of California Inc.
SEC8d
SEC Form DEF 14A filed by Pacific Biosciences of California Inc.
PR11d
PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing
PR16d
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
PR17d
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
INSIDER22d
SEC Form 4 filed by Gibson Christopher
INSIDER29d
SEC Form 4 filed by Gibson James R Ii
SEC36d
Amendment: SEC Form SCHEDULE 13G/A filed by Pacific Biosciences of California Inc.